Clinical Trial Update: Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of topical rapamycin used with pulsed dye laser in Sturge-Weber syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sturge-weber Syndrome

Drugs mentioned

• Rapamycin (sirolimus) topical (sirolimus)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Sturge- Weber Syndrome | Phase 2 | Status: COMPLETED